Hypermineralocorticoidism due to topical application of 9 alpha-fluoroprednisolone.
D000287:Administration, Topical; D002648:Child; D005438:Fludrocortisone / Q000009:adverse effects; D005477:Fluprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D008901:Mineralocorticoids / Q000378:metabolism*
D008901:Mineralocorticoids; C010958:9-fluoroprednisolone; D005477:Fluprednisolone; D005438:Fludrocortisone